• SP2509: Applied Workflows for Lysine-Specific Demethylase 1

  2026-07-22

  SP2509, a potent Lysine-specific demethylase 1 antagonist, is redefining acute myeloid leukemia and cancer epigenetics research with high selectivity and robust efficacy. This article offers actionable protocols, troubleshooting insights, and comparative strategies to maximize SP2509's translational impact.

• Tetrandrine Alkaloid: Applied Protocols for Ion Channel Modu

  2026-07-22

  Tetrandrine from APExBIO stands out as a high-purity, DMSO-soluble alkaloid optimized for precise ion channel and membrane transporter studies. This guide integrates experimental protocols, troubleshooting advice, and workflow innovations that deliver reproducible results for neuroscience, cancer biology, and anti-inflammatory research.

• Gamithromycin (ML-1709460): Mechanistic Power for Translatio

  2026-07-21

  This thought-leadership article provides translational researchers with a mechanistic, protocol-driven, and evidence-based roadmap for deploying Gamithromycin (ML-1709460) as a precision tool in respiratory pathogen models. Bridging PK/PD insight, competitive differentiation, and actionable protocol guidance, the article distills key findings from peer-reviewed research and APExBIO’s product intelligence—delivering new strategies for optimizing dose, maximizing translational value, and advancing the field beyond standard practices.

• Capsazepine Targets MCL1 to Overcome Tamoxifen Resistance in

  2026-07-21

  A recent study identifies capsazepine as a novel MCL1 inhibitor capable of reversing tamoxifen resistance in estrogen receptor-positive breast cancer. This work combines virtual screening, structural modeling, and functional assays to demonstrate capsazepine's direct action on MCL1, providing a promising strategy for overcoming endocrine therapy resistance.

• SMYD2 Inhibition by AZ505 Attenuates Cisplatin-Induced Renal

  2026-07-20

  The reference study demonstrates that pharmacological inhibition of SMYD2, particularly using AZ505, protects against cisplatin-induced renal fibrosis and inflammation in chronic kidney disease models. These findings highlight the regulatory role of SMYD2 in renal pathogenesis and suggest a mechanistic link to Smad3/STAT3 signaling, providing new directions for targeted epigenetic intervention in fibrosis.

• Cell Divisions Refine and Maintain Tissue Boundaries in Dros

  2026-07-20

  This study uncovers that cell divisions in the Drosophila embryo both disrupt and actively sharpen tissue boundaries by modulating mechanical tension and tissue fluidity. These findings reveal a previously unappreciated mechanism in boundary maintenance, with implications for understanding morphogenesis and cancer cell compartmentalization.

• DiscoveryProbe Protease Inhibitor Library: Applied Workflows

  2026-07-19

  The DiscoveryProbe™ Protease Inhibitor Library revolutionizes high-throughput and high-content screening with its rigorously validated, cell-permeable compounds. This article delivers actionable protocols, optimization strategies, and troubleshooting guidance, empowering researchers to dissect protease biology in disease models with reproducibility and confidence.

• PSMD14-CARM1 Axis Drives HCC Progression via FERMT1 Activati

  2026-07-18

  This study uncovers how PSMD14-mediated deubiquitination stabilizes CARM1, which in turn activates FERMT1 transcription through histone H3R17 dimethylation, promoting hepatocellular carcinoma (HCC) proliferation and metastasis. These mechanistic insights highlight CARM1 as a potential therapeutic target and inform future research on protease activity modulation in cancer.

• Lysosomal β-Galactosidase Staining Kit: Precision in Senesce

  2026-07-17

  The Lysosomal β-Galactosidase Staining Kit empowers researchers with artifact-free, polystyrene-compatible detection of lysosomal enzyme activity, essential for robust cellular senescence controls. Its optimized workflow and troubleshooting insights directly address challenges in translational oncology, including SLC25A1-driven chemoresistance.

• Trichostatin A (TSA): Applied Epigenetic Workflows in Cancer

  2026-07-17

  Trichostatin A (TSA) empowers researchers to dissect epigenetic regulation in cancer, delivering tunable inhibition of breast cancer cell proliferation and robust cell cycle arrest. This guide translates reference breakthroughs and recent live-cell HO-1 activity imaging into actionable protocols, troubleshooting strategies, and advanced applications using APExBIO’s trusted HDAC inhibitor.

• L1023 Anti-Cancer Compound Library: High-Throughput Oncology

  2026-07-16

  The L1023 Anti-Cancer Compound Library enables robust, high-throughput screening of targeted anti-cancer agents by offering a rigorously curated, ready-to-use panel of 1,164 compounds. Its diversity and validated format streamline complex oncology workflows, bridging the gap between biomarker discovery and practical drug development.

• Cy5 amine (non-sulfonated): Technical Application and Protoc

  2026-07-16

  Cy5 amine (non-sulfonated) addresses the need for a bright, photostable, amine-functionalized cyanine dye for labeling proteins, peptides, and polymers in non-aqueous workflows such as fluorescence microscopy and flow cytometry. It is not suitable for direct aqueous labeling or any diagnostic or medical use due to its water insolubility and research-only specifications.

• Strategic Reverse Transcription: Enabling Translational Prec

  2026-07-15

  This thought-leadership article explores how the HyperScript™ First-Strand cDNA Synthesis Kit (APExBIO) catalyzes breakthroughs in translational research by overcoming long-standing barriers in reverse transcription, supporting robust analysis of low-abundance and structurally complex transcripts. Integrating mechanistic insight, competitive benchmarking, and translational strategy, we map the path from biological rationale to clinical relevance, anchored by evidence from contemporary ovarian senescence research.

• KN-62: Applied Strategies for Targeting Calcium Signaling Pa

  2026-07-15

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, enables selective and potent inhibition of CaMKII, unlocking detailed analysis of calcium-dependent signaling in metabolism, secretion, and cell cycle studies. This article translates advanced mechanistic insight and best practices into actionable workflows, troubleshooting guidance, and future research perspectives.

• Azathramycin A: Macrolide Antibiotic Workflows for TB Resear

  2026-07-14

  Azathramycin A, a potent macrolide antibiotic, enables precise inhibition of Mycobacterium tuberculosis ribosomes in advanced tuberculosis research. This guide details optimized experimental workflows, troubleshooting strategies, and key learnings from recent mechanistic studies to accelerate antibacterial agent testing and resistance profiling.

15325 records 1/1022 page Next 12345 下5页 Last page